Further Reading
Erectile Dysfunction
- Adapted from Montorsi et al. Am J Cardiol 2005; 96: 19M–23M
- Adapted from Saenz de Tejada I et al. In: Erectile dysfunction. Jardin A et al. (eds). 2000; 65–102.
- Baniel J, Israilov S, Segenreich E, Livne PM. Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy. BJU Int 2001;88:58-62.
- Blount MA et al. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol. 2004 Jul;66(1):144-52.
- Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol 1993;149:290-294.
- Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology 1995;45:498-502.
- Eardley I. et al. JSM 2009 accepted for publication
- European Association of Urology - Guidelines on Erectile Dysfunction 2005
- Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT, Kadesky MC, Clark AR, Roehrborn CG. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998;160:2041-2046.
- Goldstein I et al. Diabetes Care 2003; 26: 777–83
- Gresser U et al. Eur J Med Res 2002; 7: 435–46;
- Guay AT, Perez JB, Velasquez E, Newton RA, Jacobson JP. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection. Eur Urol 2000;38:671-676. http:/anti-infectives/Paris-Event/Live-Webcast.cfmwww.ncbi.nlm.nih.gov/entrez/query
- Hatzichristou D, Hatzimouratidis K, Bekas M, Apostolidis A, Tzortzis V, Yannakoyorgos K. Diagnostic steps in the evaluation of patients with erectile dysfunction. J Urol 2002;168:615-620.
- Hatzichristou DG, Hatzimouratidis K, Apostolidis A, Ioannidis E, Yannakoyorgos K, Kalinderis A. Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test. Eur Urol 1999;36:60-67.
- Hatzichristou DG, Hatzimouratidis K, Ioannides E, Yannakoyorgos K, Dimitriadis G, Kalinderis A. Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse. J Urol 1998;159:1921-1926.
- Hatzimouratidis K et al. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol. 2009 Feb;55(2):334-47.
- Heaton JP, Lording D, Liu SN, Litonjua AD, Guangwei L, Kim SC, Kim JJ, Zhi-Zhou S, Israr D, Niazi D, Rajatanavin R, Suyono S, Benard F, Casey R, Brock G, Belanger A. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res 2001;13:317-321.
- Holloway FB, Farah RN. Intermediate term assessment of the reliability, function and patient satisfaction with the AMS700 Ultrex penile prosthesis. J Urol 1997;157:1687-1691.
- Horasanli K et al. Do lifestyle changes work for improving erectile dysfunction? Asian J Androl. 2008 Jan;10(1):28-35.
- Johannes CB, Araujo AB , Feldman HA. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study. J Urol. 163: 2000; 460-463.
- Kattan S. Double-blind randomized crossover study comparing intracorporeal prostaglandin E1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence. Urology 1995;45:1032-1036.
- Kolotkin RL et al. Obesity and sexual quality of life. Obesity (Silver Spring). 2006 Mar;14(3):472-9.
- Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol 1990;143:1138-1141.
- Leungwattanakij S, Flynn V, Jr., Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001;28:343-354.
- Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001;28:335-41, ix-x.
- Lewis RW, Weldon K, Nemo K, the MUSE-ACTIS Study Group. Combined use of transurethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: results from a multicentre trial. Int J Impot Res 1998;10:S49 (365). UPDATE MARCH 2005 25
- Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol 1997;15:78-82.
- Linet OI, Ogrinc FG. Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction. N Engl J Med 1996;334:873-877.
- Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-1813.
- Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson K-E, Althof S et al. Summary of the Recommendations on Sexual Dysfunctions in Men. J Sexual Medicine 2004;1:6-23.
- Martin-Morales A. et al., ESSM 2009, oral presentation.
- McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000 Oct;12 Suppl 4:S6-S11.
- Meuleman EJ, Diemont WL. Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am 1995;22:803-819.
- Miner M et al. J Sex Med 2008; 5: 1455–67.
- Montague DK, Angermeier KW. Penile prosthesis implantation. Urol Clin North Am 2001;28:355-361,
- Montorsi F et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008 Oct;54(4):924-3.
- Montorsi F et al. J Sex Med 2004; 1: 168–78.
- Montorsi F, Salonia A, Zanoni M, Pompa P, Cestari A, Guazzoni G, Barbieri L, Rigatti P. Current status of local penile therapy. Int J Impot Res 2002;14(Suppl 1):S70-81.
- Morales A, Heaton JP. Hormonal erectile dysfunction. Evaluation and management. Urol Clin North Am 2001;28:279-288.
- Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein I. Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy [see comments]. J Urol 1997;158:1752-1758; discussion 1758-1759
- Mulhall JP, Jahoda AE, Ahmed A, Parker M. Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use. Urology 2001;58:262-266.
- NIH Consensus Conference. "NIH Consensus Development Panel on Impotence." Journal of the American Medical Association: 270 (1993): 83-90.
- Padma-Nathan H et al. J Sex Med 2007; 4: 152–61.
- Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson CA, Shabsigh R, Tam PY. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group [see comments]. N Engl J Med 1997;336:1-7.
- Porst H et al. Urology 2003; 62: 519–23; discussion 523–4.
- Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996;155:802-815. UPDATE MARCH 2005 23
- Rosen R et al. J Men’s Health 2009; 6(3): 229–75.
- Rosenberg M et al. Int J Clin Prac 2009; 63: 27–34.
- Saenz de Tejada I et al. Int J Impot Res 2001; 13: 282–90.
- Shabsigh R et al. Curr Med Res Opin 2007; 23: 2453–60.
- Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000;55:477-480.
- Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicentre study. Urology 2000;55:109-113.
- Spollett GR. Diabetes Educ 1999; 25(1): 65-73.
- Tefilli MV, Dubocq F, Rajpurkar A, Gheiler EL, Tiguert R, Barton C, Li H, Dhabuwala CB. Assessment of psychosexual adjustment after insertion of inflatable penile prosthesis. Urology 1998;52:1106-1112.
- Valiquette L et al. Int J Clin Pract 2006; 60: 1378–85.
- Van Ahlen H et al.J Sex Med 2005;2: 856–64.
- Vardi Y, Saenz de Tejada I. Functional and radiologic evidence of vascular communication between the spongiosal and cavernosal compartments of the penis. Urology 1997;49:749-752.
- Wespes, E, Amar, E, Hatzichristou, D, Hatzimouratidis, K, Montorsi, F, Pryor, J, Vardi Y; EAU. EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006 May;49(5):806-15.
- Zitzmann M et al. J Clin Endocrinol Metab 91(11): 4335-4343 (2006)
